Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Gene therapy AMT-130 slowed Huntington’s progression by up to 75% in a small study, but results need larger trials for confirmation.

flag A gene therapy called AMT-130 slowed Huntington’s disease progression by up to 75% in a small, unreviewed study of 29 patients, with higher-dose recipients showing the most benefit over 36 months. flag Delivered via brain surgery, the treatment reduced harmful huntingtin protein levels and nerve damage markers in spinal fluid, with improvements in movement, cognition, and daily function. flag While well-tolerated, side effects were linked to the invasive procedure. flag Experts caution that results are preliminary, based on external comparisons rather than a controlled trial, and require confirmation through larger studies before regulatory approval, which uniQure plans to seek in 2026.

10 Articles